Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

TPN Bulk Compounding from Bulk Drug Substances

Author(s):  Chamallas Stanley N

Issue:  Sep/Oct 1998 - Parenteral Nutrition Solutions
View All Articles in Issue

Page(s):  347-349

TPN Bulk Compounding from Bulk Drug Substances Page 1
TPN Bulk Compounding from Bulk Drug Substances Page 2
TPN Bulk Compounding from Bulk Drug Substances Page 3

Download in electronic PDF format for $75

Abstract:  Bulk total parenteral nutrition compounding is the process whereby a patient’s entire prescription is prepared in one vessel rather than by one unit at a time. In this discussion, the author covers methodology, compounding of total parenteral nutrition, filling the bags, quality control of the compounded product, facility and equipment. Tables provide information regarding equipment for use in bulk compounding of total parenteral nutrition solutions, sample supplies required for bulk compounding of these solutions, and example standard operating procedures for aseptic bulk compounding of total parenteral nutrition solutions. The author concludes that bulk compounding of total parenteral nutrition solutions can be accomplished if great attention is paid to details. The large volume of some facilities requires bulk compounding to speed the delivery of total parenteral nutrition solutions to all patients served. Bulk compounding provides for more uniform preparation of products, while allowing for patient individuality.

Related Keywords: Pyrogen

Related Categories: INFUSION, PARENTERALS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
TPN Bulk Compounding from Bulk Drug Substances
Chamallas Stanley N
Sep/Oct 1998
Pg. 347-349

U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
Jul/Aug 2015
Pg. 303-305

Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding
Chan Debora Schotik
Mar/Apr 2001
Pg. 97-100

Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Cabaleiro Joe
Sep/Oct 2021
Pg. 358-362

Storage of Bulk Chemicals and Finished Preparations
Allen Loyd V Jr
Nov/Dec 2003
Pg. 464-465

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Quality-Control Analytical Methods: Determination of Tapped Bulk Volume for Compounded Prescriptions
Al-Achi Antoine
, Siddoju Srujana
May/Jun 2005
Pg. 207

Standard Operating Procedure: Procedures in the Event of Nonconformance of Bulk Chemicals or Compounded Preparations
Allen Loyd V Jr
Sep/Oct 2006
Pg. 381

Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A
Blankenship Cynthia E
Sep/Oct 2014
Pg. 379-380

Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
Jul/Aug 2004
Pg. 269-274

The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act
Pore R David
Nov/Dec 2012
Pg. 446-450

Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
Jan/Feb 2020
Pg. 30-36

The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene
, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Jan/Feb 2014
Pg. 6-12

U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013
Miller David G
Jan/Feb 2014
Pg. 35-36

Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations
McCrory Gary
Mar/Apr 2016
Pg. 95-96

Standing Together Fixing the Drug Quality and Security Act
Miller David G
Mar/Apr 2015
Pg. 104-106

PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Williams LaVonn A
Nov/Dec 2011
Pg. 526-527

Quality Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 1
Dubczak John
, Latta Kenneth S, Hedman Hilary, Smith Donald R
Sep/Oct 2010
Pg. 407-414

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Return to Top